Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, 6(79), p. 846-848, 2020
DOI: 10.1136/annrheumdis-2019-216702
Links
Tools
Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries
Journal article published in 2020 by
Bente Glintborg 
,
Stylianos Georgiadis ,
Anne Gitte Loft ,
Asta Linauskas,
Hanne Lindegaard,
Oliver Hendricks,
Dorte V. Jensen,
Birgitte Lange Andersen,
Kamilla Danebod,
Anders Villumsen,
Grith Eng,
Charlotte Wiell,
Natalia Manilo,
Salome Kristensen,
Johnny Raun
and other authors.
,
Stylianos Georgiadis ,
Anne Gitte Loft ,
Asta Linauskas,
Hanne Lindegaard,
Oliver Hendricks,
Dorte V. Jensen,
Birgitte Lange Andersen,
Kamilla Danebod,
Anders Villumsen,
Grith Eng,
Charlotte Wiell,
Natalia Manilo,
Salome Kristensen,
Johnny Raun
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 